Pharmacokinetics and Acceptability of Once- Versus Twice-Daily Lamivudine and Abacavir in HIV Type-1-Infected Ugandan Children in the ARROW Trial
Antiviral Therapy - United Kingdom
doi 10.3851/imp1695
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2010
Authors
Publisher
International Medical Press